Your browser doesn't support javascript.
loading
Integrated genomic profiling and modelling for risk stratification in patients with advanced oesophagogastric adenocarcinoma.
Hao, Dapeng; He, Siyuan; Harada, Kazuto; Pizzi, Melissa Pool; Lu, Yang; Guan, Pujun; Chen, Lu; Wang, Ruiping; Zhang, Shaojun; Sewastjanow-Silva, Matheus; Abdelhakeem, Ahmed; Shanbhag, Namita; Bhutani, Manoop; Han, Guangchun; Lee, Jeffrey H; Zhao, Shuangtao; Weston, Brian; Blum Murphy, Mariela; Waters, Rebecca; Estrella, Jeannelyn Santiano; Roy-Chowdhuri, Sinchita; Gan, Qiong; Lee, Ju-Seog; Peng, Guang; Hanash, Samir M; Calin, George Adrian; Song, Xingzhi; Zhang, Jianhua; Song, Shumei; Wang, Linghua; Ajani, Jaffer A.
Afiliación
  • Hao D; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • He S; Department of Genetics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Harada K; Gastroenterological Surgery, Kumamoto University, Kumamoto, Kumamoto, Japan.
  • Pizzi MP; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lu Y; Department of Nuclear Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Guan P; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Chen L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang R; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhang S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Sewastjanow-Silva M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Abdelhakeem A; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Shanbhag N; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Bhutani M; Gastroenterology Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Han G; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lee JH; Gastroenterology Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhao S; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Weston B; Gastroenterology Hepatology and Nutrition, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Blum Murphy M; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Waters R; Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Estrella JS; Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Roy-Chowdhuri S; Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Gan Q; Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Lee JS; Systems Biology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Peng G; Clinical Cancer Prevention, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Hanash SM; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Calin GA; Translational Molecular Pathology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Song X; Computational Genomics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Zhang J; Computational Genomics, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Song S; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA.
  • Wang L; Department of Genomic Medicine, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA jajani@mdanderson.org LWang22@mdanderson.org.
  • Ajani JA; Department of Gastrointestinal Medical Oncology, The University of Texas MD Anderson Cancer Center, Houston, Texas, USA jajani@mdanderson.org LWang22@mdanderson.org.
Gut ; 70(11): 2055-2065, 2021 11.
Article en En | MEDLINE | ID: mdl-33334899
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Perfil Genético Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Gut Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Neoplasias Gástricas / Neoplasias Esofágicas / Adenocarcinoma / Perfil Genético Tipo de estudio: Etiology_studies / Prognostic_studies / Risk_factors_studies Límite: Female / Humans / Male Idioma: En Revista: Gut Año: 2021 Tipo del documento: Article País de afiliación: Estados Unidos Pais de publicación: Reino Unido